Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01E malaria vaccine in children
NCT07036159Phase 2Recruiting
- Sponsor
- GSK
- Start
- Aug 2025
- Primary completion
- Apr 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Aug 2025; status: recruiting.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07036159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07036159.